Killer Cell Activating Receptor–Associated Protein Exacerbates Intestinal Inflammation Through Promoting Kynurenine–Aryl Hydrocarbon Receptor–Dependent Neutrophil Activation in Ulcerative Colitis
4 affiliations
- 1Taishan Scholars Laboratory, Medical Research Center, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, China
- 2Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, China
- 3Center for Inflammatory Bowel Disease Research and Department of Gastroenterology, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China
- 4Department of Gastroenterology, Shanghai Tenth People’s Hospital of Tongji University, Shanghai, China
Abstract
Background & Aims: Killer cell activating receptor–associated protein, also known as TYRO protein tyrosine kinase binding protein, has been reported to participate in the regulation of autoimmunity and inflammation. However, the underlying mechanisms involved in intestinal mucosal inflammation in ulcerative colitis remain obscure.
Methods: We analyzed killer cell activating receptor–associated protein expression in colon tissues from patients with ulcerative colitis and established dextran sulfate sodium–induced colitis models in killer cell activating receptor–associated protein knockout mice to determine the potential role of killer cell activating receptor–associated protein in the induction of mucosal inflammation. To clarify the immunoregulation of neutrophils on intestinal epithelial barrier function, we cocultured neutrophils isolated from killer cell activating receptor–associated protein knockout or wild-type mice with intestinal epithelial cells. Additionally, we profiled neutrophil tryptophan metabolites using targeted metabolomics.
Results: Our data demonstrated that killer cell activating receptor–associated protein was highly expressed in the intestinal mucosal tissue and peripheral blood neutrophils of patients with active ulcerative colitis, particularly in neutrophils. Inhibition of killer cell activating receptor–associated protein promoted anti-inflammatory immune responses in neutrophils in vitro, showing a significant decrease in the expression of proinflammatory cytokines, including interleukin6, tumor necrosis factor-α, and interleukin1β. Consistently, killer cell activating receptor–associated protein deficiency alleviated dextran sulfate sodium–induced colitis in mice and improved intestinal mucosal barrier integrity via the aryl hydrocarbon receptor–interleukin22 pathway in neutrophils. Mechanistically, killer cell activating receptor–associated protein deficiency enhanced the nuclear translocation of aryl hydrocarbon receptor through the indoleamine 2,3-dioxygenase 1–kynurenine pathway in neutrophils. Notably, administration of killer cell activating receptor–associated protein knockout neutrophils alleviated mucosal inflammation in dextran sulfate sodium–induced colitis mice.
Conclusions: Overall, our study highlights the critical role of killer cell activating receptor–associated protein in mucosal inflammation in ulcerative colitis by promoting neutrophil proinflammatory immune responses and disrupting the intestinal mucosal barrier integrity, suggesting that targeting killer cell activating receptor–associated protein in neutrophils may represent a novel therapeutic approach for ulcerative colitis.
Related
- SIRT5 deficiency exacerbates sepsis acute renal injury by activating ACSL4/FTH1 axis dependent ferroptosis
- Sirtuin 4 knockout exacerbates cardiac injury in septic cardiomyopathy via activating the MAPK-JNK pathway
- NLRC3 deficiency exacerbates high-fat diet-induced enteric nervous system injury and colonic motility dysfunction in mice via activating NF-κB signaling pathway
- MAGI3 Acts as an Intestinal Epithelial Gatekeeper in Inflammation‐Associated Colorectal Cancer by Suppressing the STAT3‐CCL2 Axis and TAM‐Mediated Immunosuppression
- Sanguinarine ameliorates rheumatoid arthritis by activating the Hippo-YAP/TAZ pathway to induce apoptosis and suppress inflammation in fibroblast-like synoviocytes
BibTeX
@article{jin2026killer,
title = {{Killer Cell Activating Receptor–Associated Protein Exacerbates Intestinal Inflammation Through Promoting Kynurenine–Aryl Hydrocarbon Receptor–Dependent Neutrophil Activation in Ulcerative Colitis}},
author = {Guiyuan Jin and Fengqin Zhu and Fengxian Dai and Yan Wang and Yun Chen and Yonghong Yang and Zhanju Liu and Guangxi Zhou},
journal = {Cellular and Molecular Gastroenterology and Hepatology},
year = {2026},
month = sep,
doi = {10.1016/j.jcmgh.2026.101906},
url = {https://doi.org/10.1016/j.jcmgh.2026.101906},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Killer Cell Activating Receptor–Associated Protein Exacerbates Intestinal Inflammation Through Promoting Kynurenine–Aryl Hydrocarbon Receptor–Dependent Neutrophil Activation in Ulcerative Colitis
AU - Guiyuan Jin
AU - Fengqin Zhu
AU - Fengxian Dai
AU - Yan Wang
AU - Yun Chen
AU - Yonghong Yang
AU - Zhanju Liu
AU - Guangxi Zhou
PY - 2026
DA - 2026/09/24
JO - Cellular and Molecular Gastroenterology and Hepatology
DO - 10.1016/j.jcmgh.2026.101906
UR - https://doi.org/10.1016/j.jcmgh.2026.101906
AB - Background & Aims: Killer cell activating receptor–associated protein, also known as TYRO protein tyrosine kinase binding protein, has been reported to participate in the regulation of autoimmunity and inflammation. However, the underlying mechanisms involved in intestinal mucosal inflammation in ulcerative colitis remain obscure. Methods: We analyzed killer cell activating receptor–associated protein expression in colon tissues from patients with ulcerative colitis and established dextran sulfate sodium–induced colitis models in killer cell activating receptor–associated protein knockout mice to determine the potential role of killer cell activating receptor–associated protein in the induction of mucosal inflammation. To clarify the immunoregulation of neutrophils on intestinal epithelial barrier function, we cocultured neutrophils isolated from killer cell activating receptor–associated protein knockout or wild-type mice with intestinal epithelial cells. Additionally, we profiled neutrophil tryptophan metabolites using targeted metabolomics. Results: Our data demonstrated that killer cell activating receptor–associated protein was highly expressed in the intestinal mucosal tissue and peripheral blood neutrophils of patients with active ulcerative colitis, particularly in neutrophils. Inhibition of killer cell activating receptor–associated protein promoted anti-inflammatory immune responses in neutrophils in vitro, showing a significant decrease in the expression of proinflammatory cytokines, including interleukin6, tumor necrosis factor-α, and interleukin1β. Consistently, killer cell activating receptor–associated protein deficiency alleviated dextran sulfate sodium–induced colitis in mice and improved intestinal mucosal barrier integrity via the aryl hydrocarbon receptor–interleukin22 pathway in neutrophils. Mechanistically, killer cell activating receptor–associated protein deficiency enhanced the nuclear translocation of aryl hydrocarbon receptor through the indoleamine 2,3-dioxygenase 1–kynurenine pathway in neutrophils. Notably, administration of killer cell activating receptor–associated protein knockout neutrophils alleviated mucosal inflammation in dextran sulfate sodium–induced colitis mice. Conclusions: Overall, our study highlights the critical role of killer cell activating receptor–associated protein in mucosal inflammation in ulcerative colitis by promoting neutrophil proinflammatory immune responses and disrupting the intestinal mucosal barrier integrity, suggesting that targeting killer cell activating receptor–associated protein in neutrophils may represent a novel therapeutic approach for ulcerative colitis.
SN - 2352-345X
ER -